Enovis Revenue 2010-2024 | ENOV
Enovis revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Enovis Annual Revenue (Millions of US $) |
|
|---|---|
| 2023 | $1,707 |
| 2022 | $1,563 |
| 2021 | $1,426 |
| 2020 | $1,121 |
| 2019 | $3,327 |
| 2018 | $2,193 |
| 2017 | $1,937 |
| 2016 | $3,186 |
| 2015 | $3,434 |
| 2014 | $4,624 |
| 2013 | $4,207 |
| 2012 | $3,914 |
| 2011 | $693 |
| 2010 | $542 |
| 2009 | $525 |
| Enovis Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-09-30 | $505 |
| 2024-06-30 | $525 |
| 2024-03-31 | $516 |
| 2023-12-31 | $455 |
| 2023-09-30 | $418 |
| 2023-06-30 | $429 |
| 2023-03-31 | $406 |
| 2022-12-31 | $409 |
| 2022-09-30 | $384 |
| 2022-06-30 | $395 |
| 2022-03-31 | $375 |
| 2021-12-31 | $-169 |
| 2021-09-30 | $360 |
| 2021-06-30 | $356 |
| 2021-03-31 | $879 |
| 2020-12-31 | $-1,122 |
| 2020-09-30 | $806 |
| 2020-06-30 | $620 |
| 2020-03-31 | $816 |
| 2019-12-31 | $888 |
| 2019-09-30 | $847 |
| 2019-06-30 | $909 |
| 2019-03-31 | $684 |
| 2018-12-31 | $227 |
| 2018-09-30 | $524 |
| 2018-06-30 | $561 |
| 2018-03-31 | $881 |
| 2017-12-31 | $-489 |
| 2017-09-30 | $845 |
| 2017-06-30 | $848 |
| 2017-03-31 | $734 |
| 2016-12-31 | $585 |
| 2016-09-30 | $767 |
| 2016-06-30 | $957 |
| 2016-03-31 | $877 |
| 2015-12-31 | $529 |
| 2015-09-30 | $969 |
| 2015-06-30 | $1,025 |
| 2015-03-31 | $911 |
| 2014-12-31 | $1,206 |
| 2014-09-30 | $1,164 |
| 2014-06-30 | $1,199 |
| 2014-03-31 | $1,054 |
| 2013-12-31 | $1,171 |
| 2013-09-30 | $1,015 |
| 2013-06-30 | $1,074 |
| 2013-03-31 | $947 |
| 2012-12-31 | $1,027 |
| 2012-09-30 | $954 |
| 2012-06-30 | $1,046 |
| 2012-03-31 | $886 |
| 2011-12-31 | $178 |
| 2011-09-30 | $170 |
| 2011-06-30 | $187 |
| 2011-03-31 | $159 |
| 2010-12-31 | $167 |
| 2010-09-30 | $132 |
| 2010-06-30 | $123 |
| 2010-03-31 | $120 |
| 2009-12-31 | $131 |
| 2009-09-30 | $129 |
| 2009-06-30 | $129 |
| 2009-03-31 | $136 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $2.544B | $1.707B |
| Enovis Corporation is a medical technology company. Its range of products, services and integrated technologies fuel active lifestyles in orthopedics and beyond. Enovis Corporation, formerly known as Colfax Corporation, is based in Wilmington, DE. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $38.872B | 57.28 |
| Tempus AI (TEM) | United States | $10.232B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $8.842B | 224.83 |
| Inspire Medical Systems (INSP) | United States | $5.430B | 169.35 |
| IRhythm Technologies (IRTC) | United States | $3.397B | 0.00 |
| Privia Health (PRVA) | United States | $2.723B | 226.90 |
| Azenta (AZTA) | United States | $2.469B | 114.98 |
| Clover Health Investments (CLOV) | United States | $2.225B | 0.00 |
| Schrodinger (SDGR) | United States | $1.886B | 0.00 |
| Omnicell (OMCL) | United States | $1.826B | 39.83 |
| 10x Genomics (TXG) | United States | $1.773B | 0.00 |
| Phreesia (PHR) | United States | $1.680B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.937B | 0.00 |
| Talkspace (TALK) | United States | $0.608B | 0.00 |
| Standard BioTools (LAB) | United States | $0.529B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.507B | 0.00 |
| TruBridge (TBRG) | United States | $0.380B | 110.57 |
| Nyxoah SA (NYXH) | Belgium | $0.369B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.334B | 0.00 |
| Pulmonx (LUNG) | United States | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.233B | 0.00 |
| American Well (AMWL) | United States | $0.176B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.104B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.087B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.073B | 0.00 |
| CareCloud (CCLD) | United States | $0.066B | 0.00 |
| HeartBeam (BEAT) | United States | $0.065B | 0.00 |
| 111 (YI) | China | $0.057B | 0.00 |
| Zepp Health (ZEPP) | China | $0.045B | 0.00 |
| Outset Medical (OM) | United States | $0.043B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.043B | 0.00 |
| Zhongchao (ZCMD) | China | $0.037B | 0.00 |
| Movano (MOVE) | United States | $0.035B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.022B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.019B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.016B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.016B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.011B | 0.00 |
| Precipio (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.005B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |